Division of Internal Medicine, McGill University Health Centre, Montréal, Quebec, Canada.
Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
BMJ Case Rep. 2021 Jan 5;14(1):e235981. doi: 10.1136/bcr-2020-235981.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladder, suggesting pyleo-ureteritis with cystitis. The patient was initially treated for suspected bacterial urinary tract infection although repeated blood and urine cultures remained negative. She then received multiple transfusions for chemotherapy-induced pancytopenia while her urinary symptoms did not improve. Due to her immunocompromised status, she was tested for viral infection, which revealed, BK polyomavirus, adenovirus and cytomegalovirus in serum and urine. Cidofovir was initially administered to treat these infections while ganciclovir was used with filgrastim due to neutropenia. The patient subsequently improved. This case represents a diagnostic and therapeutic challenge due to the multiple concurrent viral infections causing haematuria as well as the combined post-chemo-immunotherapy and antiviral myelotoxicity in a CLL patient.
一位 58 岁女性患有慢性淋巴细胞白血病(CLL),在接受化疗免疫治疗后出现 2 周发热和血尿。CT 扫描显示其左侧尿道和膀胱增厚,提示肾盂输尿管炎伴膀胱炎。尽管反复进行血培养和尿培养,但仍未检出细菌,因此最初考虑为疑似细菌性尿路感染。该患者因化疗引起的全血细胞减少症而接受了多次输血,但其尿路症状并未改善。由于免疫功能低下,对其进行了病毒感染检测,结果在血清和尿液中发现 BK 多瘤病毒、腺病毒和巨细胞病毒。最初使用更昔洛韦治疗这些感染,由于中性粒细胞减少,使用粒细胞集落刺激因子联合更昔洛韦治疗。随后患者病情好转。由于多种同时存在的病毒感染导致血尿,以及 CLL 患者化疗免疫治疗后联合抗病毒药物的骨髓毒性,该病例的诊断和治疗极具挑战性。